Phenothiazines solution complexity – Determination of pKa and solubility-pH profiles exhibiting sub-micellar aggregation at 25 and 37°C

Bioconversion and P-gp-Mediated Transport of Depot Fluphenazine Prodrugs after Intramuscular Injection

Fluphenazine (FPZ) decanoate, an ester-type prodrug formulated as a long-acting injection (LAI), is used in the treatment of schizophrenia. FPZ enanthate was also developed as an LAI formulation, but is no longer in use clinically because of the short elimination half-life of FPZ, the parent drug, after intramuscular injection. In the present study, the hydrolysis of FPZ prodrugs was evaluated in human plasma and liver to clarify the reason for this difference in elimination half-lives. FPZ prodrugs were hydrolyzed in human plasma and liver microsomes. The rate of hydrolysis of FPZ enanthate in human plasma and liver microsomes was 15-fold and 6-fold, respectively, faster than that of FPZ decanoate. Butyrylcholinesterase (BChE) and human serum albumin (HSA) present in human plasma, and two carboxylesterase (CES) isozymes, hCE1 and hCE2, expressed in ubiquitous organs including liver, were mainly responsible for the hydrolysis of FPZ prodrugs. FPZ prodrugs may not be bioconverted in human skeletal muscle at the injection site because of lack of expression of BChE and CESs in muscle. Interestingly, although FPZ was a poor substrate for human P-glycoprotein, FPZ caproate was a good substrate. In conclusion, it is suggested that the shorter elimination half-life of FPZ following administration of FPZ enanthate compared with FPZ decanoate can be attributed to the more rapid hydrolysis of FPZ enanthate by BChE, HSA and CESs.

Understanding the pH Dependence of Supersaturation State-A Case Study of Telmisartan

Creating supersaturating drug delivery systems to overcome the poor aqueous solubility of active ingredients became a frequent choice for formulation scientists. Supersaturation as a solution phenomenon is, however, still challenging to understand, and therefore many recent publications focus on this topic. This work aimed to investigate and better understand the pH dependence of supersaturation of telmisartan (TEL) at a molecular level and find a connection between the physicochemical properties of the active pharmaceutical ingredient (API) and the ability to form supersaturated solutions of the API. Therefore, the main focus of the work was the pH-dependent thermodynamic and kinetic solubility of the model API, TEL. Based on kinetic solubility results, TEL was observed to form a supersaturated solution only in the pH range 3–8. The experimental thermodynamic solubility-pH profile shows a slight deviation from the theoretical Henderson–Hasselbalch curve, which indicates the presence of zwitterionic aggregates in the solution. Based on pK_a values and the refined solubility constants and distribution of macrospecies, the pH range where high supersaturation-capacity is observed is the same where the zwitterionic form of TEL is present. The existence of zwitterionic aggregation was confirmed experimentally in the pH range of 3 to 8 by mass spectrometry.

Disproportionation of Pharmaceutical Salts: pHmax and Phase-Solubility/pH Variance

A multiphasic mass action equilibrium model is used to show that the critical pH in the acid-base disproportionation of a solid salt into its corresponding solid free-base form in aqueous suspensions, widely known as "pH_max", is incompletely interpreted. It is shown that the traditional thermodynamic model does not predict the invariance of pH and solubility during the salt-to-free-base conversion process in an alkalimetric titration. Rather, the conversion entails a range of pH and solubility values, depending on the amount of added excess salt above that needed to form a saturated solution. A more precise definition is proposed for pH_max (pH at the maximum solubility of a eutectic mixture), and three new terms are introduced: pH_min (pH at the minimum solubility of the eutectic mixture), pH_δ (disproportionation invariant pH within the eutectic, i.e., the equilibrium pH of a spontaneously disproportionating salt slurry), and pH_γ (Gibbs pH at which disproportionation yields equimolar amounts of excess salt and excess free-base solids within the eutectic). Two test compounds with reported multiple salts and the free-base solubility values were selected to illustrate the expanded concepts, the bases WR-122455 and RPR-127963. Also, dibasic calcium phosphate was selected as an ionizable test excipient. The salts are designated in the study as μ-type, when they are thermodynamically stable with respect to spontaneous disproportionation in pure water (e.g., WR-122455 salts), and δ-type, when they are predicted to spontaneously disproportionate in pure water (e.g., RPR-127963 salts). In an alkalimetric titration, when an acidified suspension of a salt of a basic molecule is titrated with a strong base (e.g., NaOH), the passage across the eutectic domain (bounded by pH_max and pH_min) is often characterized by (a) minimum in ionic strength either at pH_max (μ-type salt) or pH_δ (δ-type salt) and (b) maximum buffer capacity at pH_γ. When the alkalimetric titration is performed with a large excess of added salt, a wide eutectic domain forms: pH_max and pH_δ remain invariant, but pH_min and pH_γ shift substantially in pH. The acid-base mass action model described here can be useful in predicting the stability of salt formulations in mixtures with excipients that can act as pH modifiers.

Ionizable Drug Self-Associations and the Solubility Dependence on pH: Detection of Aggregates in Saturated Solutions Using Mass Spectrometry (ESI-Q-TOF-MS/MS)

It is widely accepted that solubility-pH profiles of ionizable compounds follow the Henderson-Hasselbalch equation. However, several studies point out that compounds often undergo additional processes in saturated solutions, such as sub-micellar oligomerization, micellar aggregation, or drug-buffer complexation among others, which make the experimental profiles deviate from the behavior predicted by the Henderson-Hasselbalch equation. Often, the presence of additional processes is supported by the analysis of experimental data through solubility computer programs. However, the purpose of this work is to experimentally prove the aggregation phenomena for a series of bases for which deviations from the theoretical profile have been observed. To this end, five monoprotic bases (lidocaine, maprotiline, cyproheptadine, bupivacaine, and mifepristone) susceptible to form ionic aggregates in solution have been selected, and mass spectrometry has been the technique of choice to prove the presence of aggregation. High declustering potentials have been applied to prevent aggregates from forming in the ionization source of the mass spectrometer. In addition, haloperidol has been used as a negative control since according to its profile, it is not suspected to form ionic aggregates. In all instances, except for haloperidol, the analysis of the saturated solutions revealed the presence of mixed-charged dimers (aggregates formed by a neutral molecule and a charged one) and even trimers in the case of mifepristone and bupivacaine. For lidocaine, the most soluble of the compounds, the presence of neutral aggregates was also detected. These experiments support the hypothesis that the simple Henderson-Hasselbalch equation may explain the solubility-pH behavior of certain compounds, but it can be somewhat inaccurate in describing the behavior of many other substances.

Physicochemical Properties of Terebic Acid, MBTCA, Diaterpenylic Acid Acetate, and Pinanediol as Relevant α-Pinene Oxidation Products

The physicochemical properties and the synthesis of four α-pinene oxidation products, terebic acid, 3-methyl-1,2,3-butanetricarboxylic acid (MBTCA), diaterpenylic acid acetate (DTAA), and pinanediol, are presented in this study. The physicochemical properties encompass thermal properties, solubility in water, and dissociation constant (pK _a) for the investigated compounds. It was found that terebic acid exhibits a relatively high melting temperature of 449.29 K, whereas pinanediol revealed a low melting temperature of 329.26 K. The solubility in water was determined with the dynamic method and the experimental results were correlated using three different mathematical models: Wilson, NRTL, and UNIQUAC equations. The results of the correlation indicate that the Wilson equation appears to work the best for terebic acid and pinanediol. The calculated standard deviation was for 3.79 for terebic acid and 1.25 for pinanediol. In contrast, UNIQUAC was the best mathematical model for DTAA and MBTCA. The calculated standard deviation was 0.57 for DTAA and 2.21 for MBTCA. The measured water solubility increased in the following order: pinanediol > DTAA ≥ MBTCA > terebic acid, which affects their multiphase aging chemistry in the atmosphere. Moreover, acidity constants (pK _a) at 298, 303, and 308 K were determined for DTAA with the Bates-Schwarzenbach spectrophotometric method. The pK _a values obtained at 298, 303, and 308 K were found to be 3.76, 3.85, and 3.88, respectively.

Physicochemical Properties of Pinic, Pinonic, Norpinic, and Norpinonic Acids as Relevant α-Pinene Oxidation Products

Here, the study is focused on the synthesis and determination of physicochemical properties of four α-pinene secondary organic aerosol (SOA) products: cis-pinic acid, cis-pinonic acid, cis-norpinic acid, and cis-norpinonic acid. These encompass their thermal properties, solid-liquid phase equilibria, and dissociation constant (pK_a). Thermal properties, including the melting temperature, enthalpy of fusion, temperature, and enthalpy of the phase transitions, were measured with the differential scanning calorimetry technique. These SOA components exhibit relatively high melting temperatures from 364.32 K for cis-pinic acid to 440.68 K for cis-norpinic acid. The enthalpies of fusion vary from 14.75 kJ·mol^-1 for cis-norpinic acid to 30.35 kJ·mol^-1 for cis-pinonic acid. The solubility in water was determined with the dynamic method (solid-liquid phase equilibria method), and then experimental results were interpreted and correlated using three different mathematical models: Wilson, non-random two-liquid model, and universal quasichemical equations. The results of the correlation indicate that the Wilson equation appears to work the best for all investigated compounds, giving rise to the lowest value of a standard deviation. cis-Norpinic acid and cis-pinic acid (dicarboxylic acids) show better solubility in the aqueous solution than cis-norpinonic acid and cis-pinonic acid (monocarboxylic acids), which affect the multiphase chemistry of α-pinene SOA processes. For cis-pinonic acid and cis-norpinonic acid, also pH-profile solubility was determined. The intrinsic solubility (S₀) for cis-norpinonic acid was measured to be 0.05 mmol·dm^-3, while for cis-pinonic acid, it was found to be 0.043 mmol·dm^-3. The acidity constants (pK_a) at 298 and 310 K using the Bates-Schwarzenbach spectrophotometric method were determined. The pK_a values at 298.15 K for cis-norpinonic acid and cis-pinonic acid were found to be 4.56 and 5.19, respectively, whereas at 310.15 K, pK_a values were found to be -4.76 and 5.25, respectively.

Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations

A novel general computational approach is described to address many aspects of cocrystal (CC) solubility product (K_sp) determination of drug substances. The CC analysis program, pDISOL-X, was developed and validated with published model systems of various acid-base combinations of active pharmaceutical ingredients (APIs) and coformers: (i) carbamazepine cocrystal systems with 4-aminobenzoic acid, cinnamic acid, saccharin, and salicylic acid, (ii) for indomethacin with saccharin, (iii) for nevirapine with maleic acid, saccharin, and salicylic acid, and (iv) for gabapentin with 3-hydroxybenzoic acid. In all systems but gabapentin, the coformer is much more soluble than the API. The model systems selected are those with available published dual concentration-pH data, one set for the API and one set for the coformer, generally measured at eutectic points (thermodynamically-stable three phases: solution, cocrystal, and crystalline API or coformer). The carbamazepine-cinnamic acid CC showed a substantial elevation in the API equilibrium concentration above pH5, consistent with the formation of a complex between carbamazepine and cinnamate anion. The analysis of the gabapentin:3-hydroxybenzoic acid 1:1 CC system indicated four zones of solid suspensions: coformer (pH<3.25), coformer and cocrystal eutectic (pH3.25-4.44), cocrystal (pH4.44-5.62), and API (pH>5.62). The general approach allows for testing of many possible equilibrium models, including those comprising drug-coformer complexation. The program calculates the ionic strength at each pH. From this, the equilibrium constants are adjusted for activity effects, based on the Stokes-Robinson hydration theory. The complete speciation analysis of the CC systems may provide useful insights into pH-sensitive dissolution effects that could potentially influence bioavailability.